ALK and lymphoma: The anthracycline compound Adriamycin® (generic name doxorubicin) is a hydroxyl derivative of daunorubicin and is one of the most common anticancer drugs [20], currently being used for the treatment of a broad spectrum of solid tumors, leukemias and lymphomas, including NPM-ALK(+) ALCL [21].